Attached files
| file | filename |
|---|---|
| 8-K - CURRENT REPORT - OptimizeRx Corp | f8k083017_optimizerxcorp.htm |
Exhibit 16.1
August 31, 2017
Securities and Exchange Commission
450 Fifth Street N.W.
Washington, DC 20549
We have read the statements of OptimizeRx Corporation, pertaining to our firm included under Item 4.01 of Form 8-K dated August 30, 2017 and agree with such statements as they pertain to our firm.
Sincerely,
/s/ KLJ & Associates, LLP